PIK3CA and breast carcinoma: PIK3CA (Phosphoinositide 3-kinase p110 alpha) with a histidine to arginine mutation at position 1047 (H1047R) is a frequent mutation occurring in human breast cancer and expression of PIK3CA(H1047R) in lineage-committed basal Lgr5-positive and luminal keratin-8-positive cells led to dedifferentiation into a multipotent stem-like state [72].